Benzinga · Oct 13, 2026
UBS Maintains Buy on American Healthcare REIT, Lowers Price Target to $62
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and lowers the price target from $63 to $62.
AH
NYSE · AHR
American Healthcare REIT, Inc.
Real Estate · REIT - Healthcare Facilities
$53.23
Up+$0.22 (+0.42%)
Updated Oct 19, 2026, 5:40 AM
SID Score
5.6/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 9.69B
- P/E ratio
- 0.12
- Dividend yield
- 1.88%
- 52-week range
- $41.67 – $58.70
- Volume
- 2.34M
- Avg. volume
- 2.59M
Price performance · AHR
AHR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
AHR closed at $53.23 after 20 trading sessions, up 1.78% for the selected period.
- Last close
- $53.23
- Period change
- +1.78%
- Period low
- $49.37
- Period high
- $53.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $53.39 | $53.52 | $52.57 | $53.23 | 2.34M |
| Oct 15, 2026 | $53.35 | $53.35 | $52.64 | $53.01 | 3.71M |
| Oct 14, 2026 | $52.80 | $53.14 | $51.91 | $52.42 | 2.22M |
| Oct 13, 2026 | $53.29 | $53.29 | $52.26 | $52.53 | 2.9M |
| Oct 12, 2026 | $51.02 | $52.537 | $50.595 | $52.52 | 2.44M |
| Oct 9, 2026 | $50.69 | $51.08 | $50.26 | $50.80 | 1.71M |
| Oct 8, 2026 | $49.52 | $50.945 | $49.25 | $50.44 | 3.38M |
| Oct 7, 2026 | $50.49 | $50.81 | $49.31 | $49.37 | 4.15M |
| Oct 6, 2026 | $50.60 | $50.85 | $50.02 | $50.49 | 3.78M |
| Oct 5, 2026 | $50.33 | $51.225 | $50.27 | $50.47 | 4.05M |
| Oct 2, 2026 | $50.92 | $51.70 | $50.57 | $50.75 | 2.44M |
| Oct 1, 2026 | $51.44 | $51.44 | $50.36 | $50.69 | 2.88M |
| Sep 30, 2026 | $51.80 | $51.80 | $51.21 | $51.26 | 3.15M |
| Sep 29, 2026 | $52.02 | $52.45 | $51.62 | $52.08 | 2.62M |
| Sep 28, 2026 | $52.04 | $52.47 | $51.64 | $51.90 | 2.05M |
| Sep 25, 2026 | $52.30 | $52.48 | $51.90 | $52.02 | 2.72M |
| Sep 24, 2026 | $52.09 | $52.84 | $51.825 | $52.31 | 2.46M |
| Sep 23, 2026 | $51.51 | $52.30 | $51.31 | $51.70 | 3.87M |
| Sep 22, 2026 | $52.25 | $52.33 | $51.61 | $51.69 | 2.77M |
| Sep 21, 2026 | $53.15 | $53.15 | $52.11 | $52.30 | 2.66M |
Latest AHR news
The latest Smart Investors Daily articles mentioning AHR.
Stock researchCompany · Overview
Company
Market Activity
Research & News
AHR research
Overview
Company profile and research snapshot.
Company profile
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $49.14
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | Barclays | Overweight | — |
| Oct 13, 2026 | Raymond James | Strong Buy | — |
| Oct 13, 2026 | UBS | Buy | — |
| Sep 2, 2026 | Scotiabank | Sector Outperform | — |
| Aug 31, 2026 | Barclays | Overweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Oct 13, 2026
Barclays Maintains Overweight on American Healthcare REIT, Lowers Price Target to $60
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and lowers the price target from $66 to $60.
Benzinga · Oct 13, 2026
This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).
Benzinga · Oct 13, 2026
Raymond James Initiates Coverage On American Healthcare REIT with Strong Buy Rating, Announces Price Target of $62
Raymond James analyst David Rodgers initiates coverage on American Healthcare REIT (NYSE:AHR) with a Strong Buy rating and announces Price Target of $62.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
